---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-22-000042"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:15:05.129232+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SI-BONE posts Q3 2022 record revenue of $26.4M, up 19% YoY; guides FY22 revenue $104-105M

## Summary
- Worldwide revenue $26.4M (+19% YoY); U.S. revenue $24.6M (+21% YoY).
- Gross margin 84% vs 89% YoY, pressured by product mix, lower ASPs, and higher freight.
- Net loss $14.2M ($0.41/share) vs $15.9M ($0.48/share) in prior year.
- FY2022 revenue guidance raised to $104-105M (16-17% growth); implies Q4 of $29.5-30.5M.
- Over 800 U.S. active surgeons (+27% YoY); CMS finalized ~26-33% Medicare facility fee hike for 2023.

## SEC filing metadata
- accession: 0001459839-22-000042
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/0001459839-22-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/sibn-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-22-000042
- JSON: https://secwatch.observer/filing/0001459839-22-000042.json
- Plain text: https://secwatch.observer/filing/0001459839-22-000042.txt

## Key facts
- Earnings Releases
  SI-BONE, Inc. reported the quarter ended September 30, 2022 results: revenue $26.4 million, net income $14.2 million, EPS $0.41 per diluted share.
  - Period: the quarter ended September 30, 2022
  - Revenue: $26.4 million
  - Net income: $14.2 million
  - EPS: $0.41 per diluted share
  - Result: reported results
  source text: musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2022. Recent Highlights • Record world wide revenue of $26.4 million for the third quarter 2022, representing approximately 19% increase over the corresponding period in 2021 • Record U.S. revenue of $24.6 million for the third quarter 2022,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/0001459839-22-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.